Gastrectomy Clinical Trials

Clinical trials related to Gastrectomy Procedure

Effect of Transcutaneous Electrical Acupoint Stimulation on Gastrointestinal Recovery and Pain Control After Laparoscopic Radical Gastrectomy: A Multicenter, Randomized, Controlled Trial (GISSG+2402)

Status: Recruiting
Location: See all (8) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if transcutaneous electrical acupoint stimulation (TEAS) works to help people recover faster after laparoscopic surgery for stomach cancer. TEAS is a treatment that uses small electrical pulses through sticky pads on the skin. It does not use needles. The main questions it aims to answer are: Does TEAS help people pass gas (a sign that the digestive system is waking up) sooner after surgery? Does TEAS help lower pain after surgery? Does TEAS reduce the need for extra pain medication after surgery? Researchers will compare two groups to see if TEAS works better than a sham (inactive) treatment. Group 1 (TA group) receives real TEAS after surgery. Group 2 (SA group) receives a sham treatment at the same time points. All participants will receive the same standard pain relief and recovery care after surgery. Participants will: Be randomly assigned (like flipping a coin) to one of the two groups. Receive TEAS or sham treatment for 30 minutes starting 2 hours after waking from anesthesia, and then once daily each morning on the first 3 days after surgery. Rate their pain on a 0-10 scale at 6, 12, 24, 48, and 72 hours after surgery. Complete quality-of-life and fatigue questionnaires before surgery, on day 4 after surgery, and 30 days after surgery. Have a follow-up visit or phone call 30 days after leaving the hospital. This study includes 104 adults aged 18 to 80 years who are scheduled to have laparoscopic surgery for stomach cancer at 8 hospitals in Shandong Province, China.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 18 to 80 years, both sexes

• Endoscopically and radiographically confirmed resectable stage I-III gastric

• cancer (AJCC 8th edition)

• Scheduled to undergo laparoscopic radical gastrectomy

• Willing to sign the informed consent form and able to comply with all study procedures

Locations
Other Locations
China
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital
RECRUITING
Qingdao
Qingdao Central Hospital, University of Health and Rehabilitation Sciences
RECRUITING
Qingdao
Qingdao Chengyang District People's Hospital
RECRUITING
Qingdao
The People's Hospital of Jimo, Qingdao
RECRUITING
Qingdao
The Third People's Hospital of Qingdao
RECRUITING
Qingdao
The People's Hospital of Rizhao
RECRUITING
Rizhao
Weifang People's Hospital
RECRUITING
Weifang
Yantai Yuhuangding Hospital
RECRUITING
Yantai
Contact Information
Primary
Yi Li
zhanmusi8755@163.com
+86 0532-82911324
Backup
Yanbing Zhou, MD
zhouyanbing999@aliyun.com
+86 0532-82911324
Time Frame
Start Date: 2024-10-07
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 104
Treatments
Experimental: TA Group
Participants receive real transcutaneous electrical acupoint stimulation (TEAS) starting 2 hours after emergence from anesthesia, and once daily at 09:00 on postoperative days 1 to 3. Each session lasts 30 minutes. TEAS is delivered via the SDZ-V device with a dense-disperse wave (20 Hz alternating with 100 Hz) at the individually determined maximal tolerable threshold. Bilateral acupoints LI4, PC6, ST36, and ST37 are stimulated.
Sham_comparator: SA Group
Participants receive sham stimulation at the same time points (2 hours after emergence from anesthesia and once daily on postoperative days 1 to 3). The same SDZ-V device is used, with identical appearance, indicator lights, and sounds, but internal output leads are disconnected to deliver no electrical current. Operators simulate dial adjustments and use standardized scripts to maintain blinding.
Related Therapeutic Areas
Sponsors
Leads: The Affiliated Hospital of Qingdao University

This content was sourced from clinicaltrials.gov